Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

SELL
$32.4 - $68.18 $1.11 Million - $2.33 Million
-34,145 Reduced 76.84%
10,291 $701,000
Q2 2022

Aug 09, 2022

SELL
$22.3 - $37.39 $3,278 - $5,496
-147 Reduced 0.33%
44,436 $1.42 Million
Q1 2022

Apr 21, 2022

SELL
$25.68 - $35.59 $33,075 - $45,839
-1,288 Reduced 2.81%
44,583 $1.54 Million
Q4 2021

Feb 01, 2022

BUY
$24.9 - $40.26 $176,765 - $285,805
7,099 Added 18.31%
45,871 $1.34 Million
Q3 2021

Nov 15, 2021

BUY
$25.48 - $37.34 $273,680 - $401,068
10,741 Added 38.32%
38,772 $988,000
Q2 2021

Jul 30, 2021

SELL
$32.46 - $43.42 $38,237 - $51,148
-1,178 Reduced 4.03%
28,031 $982,000
Q1 2021

May 03, 2021

SELL
$38.94 - $50.85 $26,557 - $34,679
-682 Reduced 2.28%
29,209 $1.19 Million
Q4 2020

Jan 28, 2021

BUY
$37.65 - $63.77 $873,668 - $1.48 Million
23,205 Added 347.07%
29,891 $1.3 Million
Q2 2020

Jul 28, 2020

BUY
$48.73 - $81.82 $82,451 - $138,439
1,692 Added 33.88%
6,686 $422,000
Q1 2020

May 06, 2020

BUY
$41.72 - $87.2 $49,229 - $102,896
1,180 Added 30.94%
4,994 $255,000
Q3 2019

Oct 18, 2019

BUY
$45.35 - $57.91 $24,897 - $31,792
549 Added 16.81%
3,814 $185,000
Q2 2019

Jul 30, 2019

BUY
$52.6 - $63.29 $25,353 - $30,505
482 Added 17.32%
3,265 $172,000
Q1 2019

Apr 29, 2019

SELL
$39.99 - $53.48 $12,956 - $17,327
-324 Reduced 10.43%
2,783 $147,000
Q3 2018

Nov 09, 2018

BUY
$38.0 - $51.1 $19,798 - $26,623
521 Added 20.15%
3,107 $118,000
Q2 2018

Aug 06, 2018

SELL
$38.7 - $50.15 $32,314 - $41,875
-835 Reduced 24.41%
2,586 $117,000
Q1 2018

May 03, 2018

BUY
$39.6 - $65.9 $20,433 - $34,004
516 Added 17.76%
3,421 $165,000
Q4 2017

Jan 31, 2018

BUY
$29.7 - $45.7 $16,335 - $25,135
550 Added 23.35%
2,905 $114,000
Q3 2017

Nov 08, 2017

BUY
$25.1 - $31.05 $59,110 - $73,122
2,355
2,355 $73,000

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.